share_log

回盛生物(300871.SZ)拟向实控人控制的企业定增募资不超2.5亿元 发行价9.57元/股

Huisheng Biotech (300871.SZ) plans to raise no more than 250 million yuan in capital from enterprises controlled by actual controllers, with an issue price of 9.57 yuan/share

Zhitong Finance ·  Apr 3 10:04

Huisheng Biotech (300871.SZ) disclosed plans to issue A-shares to specific targets in 2024. This issuance...

According to the Zhitong Finance App, Huisheng Biotech (300871.SZ) disclosed plans to issue A-shares to specific targets in 2024. The target of this issuance is Chu Sheng (Hubei) Investment Partnership (Limited Partnership) (“Chu Sheng Investment”), which is an enterprise controlled by the company's actual controllers Zhang Weiyuan and Yu Jiao'e. The number of shares issued this time is no more than 26.123,300 shares (inclusive), and the issue price is 9.57 yuan/share. The total amount of capital to be raised in this offering will not exceed RMB 250 million (inclusive). After deducting the issuance fee, all will be used to supplement working capital.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment